Trial Profile
Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Nov 2015
Price :
$35
*
At a glance
- Drugs Cabozantinib (Primary)
- Indications Thyroid cancer
- Focus Pharmacokinetics
- Sponsors Exelixis
- 30 Nov 2015 New trial record